[A16-44] Sitagliptin - Benefit assessment according to §35a Social Code Book V
Last updated 15.12.2016
Commission awarded on 04.07.2016 by the Federal Joint Committee (G-BA).
Digestion, metabolism and hormones
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
|A18-65||Sitagliptin (type 2 diabetes mellitus) - Benefit assessment according to § 35a Social Code Book V (expiry of the decision)||Commission completed|
|A13-02||Sitagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)||Commission completed|